12/22/2014 - 9:44 AM EST - ProMetic Life Sciences Inc. : has entered into definitive agreements with GENERIUM Pharmaceuticals for several plasma-derived biopharmaceuticals to be manufactured and commercialized in Russia and CIS, as well as for the co-development and global commercialization of two plasma-derived coagulating factors. ProMetic Life Sciences Inc.
shares T.PLI are trading up $0.03 at $1.98.
